Stay updated on CTX001 in Severe Sickle Cell: Clinical Trial
Sign up to get notified when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.

Latest updates to the CTX001 in Severe Sickle Cell: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a consolidated Locations section listing study sites in California, Illinois, New York, Pennsylvania, Tennessee, and Texas. Removed the separate state Location subsections (California Locations, Illinois Locations, New York Locations, Pennsylvania Locations, Tennessee Locations, Texas Locations) and the HHS Vulnerability Disclosure link.SummaryDifference0.7%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedPublications section now states that items are automatically filled in from PubMed and may not all pertain to the study; the revision label was updated to v3.3.2.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page no longer displays the government funding and operating status notice that stated potential updates and access issues; this does not affect the core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedThe update shows a new Last Update Posted date (2025-08-11) on the study record, with no changes to core content, eligibility criteria, interventions, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange Detected- Added a system-wide operating status notice and version update (v3.2.0). - Removed a specific resource entry: Hb SS disease (from Genetic and Rare Diseases Information Center).SummaryDifference3%

- Check100 days agoChange DetectedUpdate replaces 'Sickle cell anemia' with 'Hb SS disease' and increments the revision from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to CTX001 in Severe Sickle Cell: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.